AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Director's Dealing Sep 22, 2021

7581_dirs_2021-09-22_7bca7e77-8ee9-472e-a6d3-4059a43bfe00.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6361M

Craneware plc

22 September 2021

Craneware plc

("Craneware" or the "Company")

Purchase of Shares

22 September 2021 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 22 September 2021, Keith Neilson, CEO of the Company, purchased 2,128 ordinary shares of 1p each in the capital of the Company at a price of 2,350 pence per Ordinary Share.

Following the purchase of Ordinary Shares, Mr. Neilson holds 3,431,522 Ordinary Shares in the capital of the Company, representing 9.66% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1.   Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2.   Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of

instrument
Ordinary Shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s)  2,128, Price(s) £23.50
e) Aggregated information:

            i. Aggregated volume

ii. Price
N/A (single transaction)

-

-
f) Date of the transaction 2021-09-22
g) Place of the transaction London Stock Exchange (XLON)

For further information, please contact:

Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Hilary Buchanan, Robyn Fisher, Joe Pederzolli [email protected]
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster, George Sellar, Andrew Clark
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Jack Botros, Alix Mecklenburg-Solodkoff

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor financial and operational performance so they can continue to drive better outcomes for the communities they serve. Craneware's Trisus platform combines revenue integrity, cost management and decision enablement into a single SaaS-based platform. Our flagship solution, Chargemaster Toolkit®, continually earns KLAS recognition in the Revenue Cycle - Chargemaster Management category and is part of our value cycle management suite, which includes charge capture, strategic pricing, 340B compliance, claims analytics, patient engagement, revenue recovery and retention, and cost and margin intelligence solutions.

Learn more at craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKBBQDBKDCCB

Talk to a Data Expert

Have a question? We'll get back to you promptly.